eFFECTOR Therapeutics Inc. (EFTR)

Name: eFFECTOR Therapeutics Inc. (EFTR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: eFFECTOR Therapeutics Inc. (EFTR)

Stock Card

$0.00

$0.00 (0.00%)

As on 27-Aug-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

eFFECTOR Therapeutics (EFTR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.00 High: 0.00

52 Week Range

Low: 0.00 High: 0.00

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-8 Mln
ROE

-9.5 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.4
Debt to Equity

0
Book Value

$--
EPS

$-14.5
Face value

--
Shares outstanding

4,704,409

5 Years Aggregate

CFO

$-94.10 Mln

EBITDA

$-110.20 Mln

Net Profit

$-48.47 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
eFFECTOR Therapeutics (EFTR)	50.0	-62.5	-40.0	50.0	-97.4	-94.0	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
eFFECTOR Therapeutics (EFTR)	0.0	-100.0	9.2	-94.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
eFFECTOR Therapeutics (EFTR)	0.0	0.0	0.2	-34.6	-19,724.7	--	--	0.0
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	144.3	9,339.4	282.0	82.9	-28.6	11.4	140.1	11.5

Shareholding Pattern

View Details

About eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company's lead product candidate includes Zotatifin, an inhibitor of eIF4A, which is... in Phase 1/2 clinical trial to treat patients with solid tumors, as well as has completed Phase 2 clinical trial in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. It also develops Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. It has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California. Read more

CEO, President & Director

Dr. Stephen T. Worland Ph.D.
CEO, President & Director

Dr. Stephen T. Worland Ph.D.
Headquarters

Solana Beach, CA
Website

https://effector.com

FAQs for eFFECTOR Therapeutics (EFTR)

What is the current share price of eFFECTOR Therapeutics Inc (EFTR) Today?

The share price of eFFECTOR Therapeutics Inc (EFTR) is $0.00 (NASDAQ) as of 27-Aug-2026 16:00 EDT. eFFECTOR Therapeutics Inc (EFTR) has given a return of -97.42% in the last 3 years.

What is the current PB & PE ratio of eFFECTOR Therapeutics Inc (EFTR)?

Since, TTM earnings of eFFECTOR Therapeutics Inc (EFTR) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2023	-0.03	-0.22
2022	-0.06	0.18
2021	0.85	0.77
2020	--	--
2019	--	--

What is the 52 Week High and Low of eFFECTOR Therapeutics Inc (EFTR)?

The 52-week high and low of eFFECTOR Therapeutics Inc (EFTR) are Rs 0.00 and Rs 0.00 as of 30-Aug-2026.

What is the market cap of eFFECTOR Therapeutics Inc (EFTR)?

eFFECTOR Therapeutics Inc (EFTR) has a market capitalisation of $ 0 Mln as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in eFFECTOR Therapeutics Inc (EFTR)?

Before investing in eFFECTOR Therapeutics Inc (EFTR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.